Safe Management of Adverse Effects Associated with Prescription Opioids in the Palliative Care Population: A Narrative Review
Journal of Clinical Medicine · 07.05.2024 · 13 (10) · 2746
DOI: 10.3390/jcm13102746 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 07.05.2024. Verfasst von Amanda Zimmerman und 1 weiteren Autor:innen. Beteiligte Einrichtung: West Forsyth Pain Management, Winston Salem, NC 27103, USA. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Salix Pharmaceuticals.
Themen: Palliativpflege
Abstract (Originalsprache)
In the palliative care population, prescription opioids are often considered viable pain relief options. However, in this complex patient population, the adverse effects of opioid medications should be identified and managed without delay. Common adverse effects can include constipation, nausea, somnolence, dizziness, vomiting, and pruritus. Less common adverse effects can include potentially lethal respiratory depression and cardiovascular effects. Critical aspects of safe opioid prescribing are recognition of side effects and knowledge of effective management strategies; prompt management is necessary for uninterrupted pain relief. Most complications are managed with general approaches such as dose reduction, opioid rotation, alternate routes of administration, and symptomatic management. The only opioid-induced complication for which US Food and Drug Administration-approved treatments currently exist is constipation. Treating laxative-refractory opioid-induced constipation (OIC) with peripherally acting mu-opioid receptor antagonists (PAMORAs), which block gastrointestinal opioid receptors, can restore gastrointestinal motility and fluid secretion. This narrative review discusses key complications of prescription opioid treatment and their management in the palliative care setting.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- West Forsyth Pain Management, Winston Salem, NC 27103, USA.
- Salix Pharmaceuticals, Bridgewater, NJ 08807, USA.
ORCID-Profile: Amanda Zimmerman
Förderung
- Salix Pharmaceuticals
Zitieren
APA
Zimmerman, A., & Laitman, A. (2024). Safe Management of Adverse Effects Associated with Prescription Opioids in the Palliative Care Population: A Narrative Review. Journal of Clinical Medicine, 13(10), 2746. https://doi.org/10.3390/jcm13102746
Vancouver
Zimmerman A, Laitman A. Safe Management of Adverse Effects Associated with Prescription Opioids in the Palliative Care Population: A Narrative Review. Journal of Clinical Medicine. 2024;13(10):2746. doi:10.3390/jcm13102746
BibTeX
@article{Zimmerman2024,
author = {Zimmerman, Amanda and Laitman, Adam},
title = {Safe Management of Adverse Effects Associated with Prescription Opioids in the Palliative Care Population: A Narrative Review},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {10},
pages = {2746},
doi = {10.3390/jcm13102746}
}
EUVIMED